Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on November 24, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Independent Validation and Verification (IV&V) Services for the REACT Program

Awarded
75N99226R00001Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541990
New
Federal
Employee Assistance Program – Human Resources Office (HRO)
Solicitation # W91SMC27RA001
Solicitation W91SMC27RA001 is a Firm-Fixed-Price contract to provide an Employee Assistance Program (EAP) for approximately 600 Illinois Army National Guard employees. The scope of work involves providing assessments, counseling, and referrals to help employees manage life challenges affecting health, personal well-being, and job performance, specifically addressing stress, office conflicts, family problems, and substance use disorders. Key requirements include operating a 24/7/365 toll-free intake hotline and online support, providing referral services to qualified providers within 60 miles of employee duty locations or homes of record in Illinois, and offering up to five counseling sessions per issue per employee delivered by licensed counselors. The contractor must meet all certification requirements in accordance with the Certified Employee Assistance Professional (CEAP) credential and provide quarterly usage reports to the Contracting Officer's Representative within 30 days of the quarter's end. The contract consists of one base year running from January 1, 2027, to December 31, 2027, with four subsequent 12-month option years extending through December 31, 2031. This is a Total Small Business Set-Aside. Award will be made based on the Lowest Price Technically Acceptable (LPTA) criteria, where technical proposals are evaluated on a pass/fail basis for compliance with the Performance Work Statement. Proposals must be submitted electronically by December 14, 2026. Performance is centered in Springfield, Illinois, with acceptance based on the contractor satisfying the tasks identified in the Performance Work Statement, Performance Requirement Summary, and Deliverable List.
W7M6 Uspfo Activity Il Arng

POSTED

about 21 hours ago

DEADLINE

in 24 days

AI Contract Overview

Show more

The Advanced Research Projects Agency for Health (ARPA-H) has issued solicitation 75N99226R00001 for Independent Validation and Verification (IV&V) services to support its Resilient Extended Automatic Cell Therapies (REACT) program, focusing on developing wireless implantable medical devices for chronic disease surveillance and treatment. The contract, with an estimated total value of approximately $19.5 million, covers a base period from February 23, 2026, through February 22, 2027, and includes two successive option periods extending through August 22, 2028. The REACT program’s key products include the “Living Pharmacy” device, which delivers tunable therapeutic molecules on demand, and the “Living Sentinel” device, engineered to monitor disease biomarker status. Central to this contract is the IV&V of engineered or differentiated cell lines critical to these devices, ensuring their standardization and reproducibility to meet FDA requirements and enable scalable manufacturing. The contract is structured as a time-and-materials agreement, encompassing labor, travel, special studies, and related direct costs. The contractor will be responsible for characterizing unmodified pancreatic cells and REACT performer cells, validating the therapeutic outputs and biomarker detection capabilities of the devices, and delivering comprehensive technical reports on critical quality attributes (CQAs), process parameters, and materials, all aligned with regulatory and manufacturing standards. Deliverables include monthly updates, interim and final progress reports, and technical assessments. Work performance is primarily at contractor or designated performer sites with virtual government oversight, spanning a multi-year period. Compliance with a broad suite of Federal Acquisition Regulation (FAR) clauses and Department of Health and Human Services (HHS) deviations is required, emphasizing ethical business conduct, system security, fair labor standards, and small business subcontracting goals. Evaluation of proposals will prioritize technical and management approaches equally, with price as a tertiary factor, and award will be based on best value. The submission deadline for proposals is January 5, 2026, with stringent formatting and content guidelines for technical, management, and price volumes. Electronic invoice submission via the Department of Treasury Invoice Processing Platform (IPP) is mandated, and subcontracting plans consistent with HHS requirements are also necessary given the contract’s anticipated size.

General Info

ARPA-H seeks IV&V services for wireless implantable devices under $19.5M contract through 2028.

NAICS

541990 - All Other Professional, Scientific, and Technical Services

Place of Performance

Washington, DC, USA

Set-Aside

unrestricted

Documents

3
DOCX, High priority: read this first6 pages · subcontracting-plan-template
High
PDF, High priority: read this first9 pages · sow
High
PDF, High priority: read this first41 pages · rfp
High

Read all 3 documents

Every page of every file, in your free workspace.

Read the documents

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

View Full Breakdown

This one is closed. Find the next one like it.

Open contracts like this one, right now:

  • DETROIT JCC-2026-40 BACKFLOW PREVENTER TESTING, MAINTENANCE & INSPECTIONOpen now, due in 192 days
  • Certified Legal Interpretation and TranslationOpen now, due in 19 days
See open contracts like this

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

PhaseAwarded
Posted

Combined Synopsis

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)
Contacts2 people available
OfficeWashington, DC, 20005, USA

Full Description

Show more

This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with part 12. This announcement constitutes the only solicitation. Offers are being requested and a separate written solicitation will not be issued.


Please refer to the attachments for full details.


The Advanced Research Projects Agency for Health (ARPA-H) Resilient Systems Office (RSO) requires independent validation and verification (IV&V) services for its Resilient Extended Automatic Cell Therapies (REACT) program. The REACT program is developing wireless implantable medical devices for the surveillance and treatment of chronic diseases that can ultimately make it to the commercial market as an affordable health care device. The objective is for the devices to interface with patients through a software platform, allowing for confirmation of therapy delivery or current disease status. The “Living Pharmacy” device will deliver tunable therapeutic molecules on demand, while the “Living Sentinel” device will track disease biomarker status. A critical component of the devices is engineered and/or differentiated cell lines (herein, “cells”) that deliver therapies or track biomarker status, respectively. IV&V is required by the REACT team to achieve standardization and reproducibility of cells so the program can scale up the manufacturing capability for the Living Pharmacy and Living Sentinel.

More opportunities from Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)

Same awarding agency

NAICS: 541715
New
Federal
Brain Repair of Any Injured Neural Structure (BRAINS)
Solicitation # ARPA-H-SOL-26-148
The Advanced Research Projects Agency for Health (ARPA-H) has issued solicitation ARPA-H-SOL-26-148 for the Brain Repair of Any Injured Neural Structure (BRAINS) Exploratory Topic program. This 18-month initiative aims to develop technologies for regrowing region-specific brain tissue to restore function lost to injury or disease, specifically targeting areas such as the hippocampus, amygdala, and cerebellum, while excluding the neocortex and spinal cord. The program is divided into two technical areas focusing on the generation of precursor tissue and the validation of surgical delivery. Successful proposals must demonstrate that precursor tissue is over 80% similar to natural counterparts and that grafted tissue achieves vascularization within 48 hours and survives for at least 21 days. The government intends to award multiple Other Transaction agreements to proposers whose solutions are most advantageous, with no set-aside used for this solicitation. Evaluation is based on scientific and technical merit, proposer capabilities, and cost reasonableness. Interested parties must first submit a mandatory solution summary before submitting full proposals. The submission process is divided into two intake groups: Group 1 has solution summaries due July 9, 2026, and full proposals due August 6, 2026; Group 2 has solution summaries due January 7, 2027, and full proposals due February 6, 2027. All submissions must be made through the ARPA-H Solution Submission Portal and must comply with HHS regulations regarding human stem cells and research security, including strict restrictions on funding foreign entities in countries of concern.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 21 hours ago

DEADLINE

in 7 months
View Details
NAICS: 541714
New
Federal
Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)
Solicitation # ARPA-H-SOL-26-164
The Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS) program, managed by the Advanced Research Projects Agency for Health (ARPA-H) Proactive Health Office, seeks to replace fragmented clinical development models with a persistent adaptive platform. This five-year initiative is divided into a 24-month platform and capability buildout stage followed by a 36-month validation and deployment stage. The program focuses on three key technical areas: a Phaseless Design Engine, Continuous Inference, and Agentic Operations, with the goal of reducing the time, cost, and failure rates of drug and biologic development through in silico capabilities and a seamless clinical-development framework. ARPA-H anticipates awarding multiple Other Transaction (OT) Agreements to proposers whose solutions are deemed most advantageous at reasonable prices, based on innovation, feasibility, and technical merit. Eligible entities must have an active SAM registration and a Unique Entity Identifier (UEI). The selection process involves a multi-stage submission of Solution Summaries and Solution Pitch packages, which must include a pitch deck, Gantt chart, preliminary master protocol, and a scope of work. All inquiries and submissions are managed through the ARPA-H Solutions site, with the initial Solution Summary deadline set for November 30, 2026. There is no specific set-aside status for this solicitation.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

7 days ago

DEADLINE

in 11 days
View Details
NAICS: 541715
Federal
Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA)
Solicitation # ARPA-H-SOL-26-163
The Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA) program, issued by the Advanced Research Projects Agency for Health (ARPA-H) Proactive Health Office under solicitation ARPA-H-SOL-26-163, seeks innovative solutions to identify and act upon autism trajectories across the lifespan. The program focuses on the nonlinear interactions of genetic, biological, behavioral, and environmental factors to move toward personalized care. The scope is divided into four Technical Areas: TA1 focuses on multi-factor analysis and trajectory identification; TA2 involves population-scale modeling and data integration; TA3 centers on precision intervention and trajectory testing; and TA4 targets technologies for communication, quality of life, and embedded assessment. Awards will be made using Other Transaction (OT) instruments through a two-stage submission process consisting of a Solution Summary and a Full Proposal. Technical performance is monitored via a milestone-based system with evaluation gates at Month 10, Month 22, and a final evaluation at Month 46. Key requirements include strict adherence to HIPAA Privacy Rule de-identification standards, the implementation of independent data safety monitoring boards for harm surveillance, and the disclosure of any organizational conflicts of interest. Submissions must follow specific formatting guidelines, including the use of Avenir Next LT Pro font for summaries and a multi-volume structure for full proposals, with a response deadline of December 2, 2026.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

11 days ago

DEADLINE

in 12 days
View Details
NAICS: 541714
Federal
ARPA-H Emerging Health Innovators (EHI) Initiative
Solicitation # ARPA-H-SOL-26-150
The ARPA-H Emerging Health Innovators (EHI) Initiative, solicitation ARPA-H-SOL-26-150, is a program designed to identify and engage early-career investigators to develop cutting-edge biomedical, health, and community-engaged research. The initiative focuses on 16 specific topic areas, including AI in life sciences, brain stimulation, and human tissue platforms. This solicitation utilizes a two-step submission process consisting of an initial Solution Summary and a subsequent Full Proposal. Eligible applicants must be led by a principal investigator who has completed their first terminal degree within the last eight years. There is no set-aside used for this solicitation. Anticipated awards will be structured as Multiple Other Transaction (OT) Agreements, which are not subject to the Federal Acquisition Regulation. Each award has a total value not to exceed $1,050,000, consisting of a 24-month base period capped at $700,000 and an optional 12-month Director's Award period capped at $350,000. Payments are issued as fixed amounts upon the successful completion of objective, measurable milestones. The tentative award start date is June 30, 2027, with full proposals due by February 10, 2027. All submissions must be processed through the ARPA-H Solutions site, and proposers must maintain active registration in SAM.gov.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

29 days ago

DEADLINE

in 3 months
View Details
NAICS: 541714
Federal
UNifying Imaging with QUantum Entanglement (UNIQUE) Innovative Solutions Opening (ISO)
Solicitation # ARPA-H-SOL-26-162
The Advanced Research Projects Agency for Health (ARPA-H) is seeking innovative solutions through the UNifying Imaging with QUantum Entanglement (UNIQUE) program, solicitation number ARPA-H-SOL-26-162. This 18-month, two-phase initiative aims to develop a new biomedical imaging paradigm by integrating anatomical, functional, and molecular data using quantum-derived observables and entangled 511 keV photon pairs. The scope is divided into two technical areas: the Imaging Core, which focuses on physical systems for generating and measuring quantum observables, and the Computational Foundation, which focuses on AI-driven reconstruction and multimodal data fusion. ARPA-H anticipates awarding multiple Other Transaction Agreements to eligible universities, non-profit organizations, and businesses. The submission process is two-staged, requiring Solution Summaries by late October 2026 and Full Proposals by December 15, 2026. Full proposals must consist of three volumes covering technical and management plans, cost proposals, and administrative requirements. Evaluation is based on technical innovation and feasibility, proposer expertise, potential to transform biomedicine, and cost reasonableness. Notably, for-profit organizations that are not small businesses under NAICS 541714 are required to provide a meaningful cost share. All participants must adhere to strict HHS regulations regarding human stem cell research and prohibitions on dangerous gain-of-function research and funding for foreign entities in countries of concern.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 2 months ago

DEADLINE

in 26 days
View Details

Get AI-powered intelligence on the opportunities still open

Every solicitation package arrives shredded into a compliance breakdown and matched to your past performance, with incumbent history and alerts on amendments and award.

Miguel
Hillary
Keith Deutsch
Christine

Join 900+ contractors already using CLEATUS